Gerben van der Vries

Gerben van der Vries is an active researcher specializing in genetics and rare disease research. He is prominently involved with the SOLVE-RD Consortium, a European initiative focused on solving rare diseases through advanced genomic analysis and integrated data infrastructure.

His research interests span several critical areas in modern genetics:

• Genetics and Genomic Analysis
• Exome and Genome Sequencing
• Rare Disease Diagnostics
• Nanopore Long-Read Sequencing
• Copy-Number Variation Analysis

Dr. van der Vries's research focuses on developing and implementing advanced genomic technologies for diagnosing rare neurological disorders, with particular emphasis on nanopore sequencing for detecting repeat expansions that conventional methods often miss. His work also addresses critical challenges in data integration for large-scale rare disease research across European institutions. His publication 'Solving patients with rare diseases through programmatic reanalysis of genome-phenome data' (2021) has been particularly influential in the field.

His contributions have been recognized through citations and downloads of his work, with his 2021 paper on programmatic reanalysis accumulating 48 Scopus citations. His recent 2025 publication on nanopore sequencing demonstrates his continued active engagement in cutting-edge research.

Dr. van der Vries has presented his work at academic conferences including BioSB 2020, where he participated as a contributor, demonstrating his active engagement with the bioinformatics research community. His research contributes to several United Nations Sustainable Development Goals related to health and well-being.